Oxabolone cipionate
 | |
| Clinical data | |
|---|---|
| Trade names | Steranabol Depo, Steranabol Ritardo |
| Routes of administration | Intramuscular injection[1] |
| ATC code | A14AB03 (WHO) |
| Identifiers | |
| |
| Synonyms | FI-5852 |
| CAS Number |
1254-35-9  |
| PubChem (CID) | 68952 |
| ChemSpider |
62175  |
| UNII |
5RXY50Q01N |
| KEGG |
D01149 |
| Chemical and physical data | |
| Formula | C26H38O4 |
| Molar mass | 414.578 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (what is this?) (verify) | |
Oxabolone cipionate (INN, JAN) (brand names Steranabol Depo, Steranabol Ritardo; former developmental code name FI-5852), or oxabolone cypionate, also known as 4-hydroxy-19-nortestosterone 17β-cypionate or estr-4-en-4,17β-diol-3-one 17β-cypionate, is synthetic, injected anabolic-androgenic steroid (AAS) and derivative of 19-nortestosterone (nandrolone) that has been marketed in Europe.[2][3][1] It is the C17β cypionate ester and a prodrug of oxabolone (4-hydroxy-19-nortestosterone).[2][3]
See also
- 4-Hydroxytestosterone
- Clostebol (4-chlorotestosterone)
- Formestane (4-hydroxyandrostenedione)
- Norclostebol (4-chloro-19-nortestosterone)
References
- 1 2 H.-L. Krüskemper (22 October 2013). Anabolic Steroids. Elsevier. pp. 203–. ISBN 978-1-4832-6504-9.
- 1 2 J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1–. ISBN 978-1-4757-2085-3.
- 1 2 Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 764–765. ISBN 978-3-88763-075-1.
This article is issued from Wikipedia - version of the 11/18/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.